Biotechnology Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity Why Is Protara Therapeutics Stock Trading Lower On Friday? – Protara Therapeutics (NASDAQ:TARA) Read more
Biotechnology Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology After Brain Cancer Data, Candel Therapeutics’ Shares Good News From Pancreatic Cancer Study Why Candel Therapeutics Stock Is Soaring On Thursday – Candel Therapeutics (NASDAQ:CADL) Read more
Biotechnology CureVac, GSK Partner Release Data On Influenza Vaccine Study – CureVac (NASDAQ:CVAC), GSK (NYSE:GSK) Read more
Biotechnology How Much Does It Cost To Make Novo Nordisk’s Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows – Novo Nordisk (NYSE:NVO) Read more
Stockmarkets AI fails to detect depression signs in social media posts by Black Americans, study finds Reuters via biedexmarkets.com Read more
Economic News European Championship won’t save German economy, study shows Reuters via biedexmarkets.com Read more
Biotechnology Relief For Dry Eye Disease? OKYO Pharma’s Candidate Shows Durable Pain Relief In Mid-Stage Study – OKYO Pharma (NASDAQ:OKYO) Read more
Biotechnology After Failed Prostate Cancer Study Merck’s Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study – Merck & Co (NYSE:MRK) Read more